Inspire's Cystic Fibrosis Treatment Misses Key Goals - WSJ.com
Links shared publicly online about this topic.
- 608total visits
Inspire's Cystic Fibrosis Treatment Misses Key Goals - WSJ.com
Inspire Pharmaceuticals said its cystic-fibrosis drug candidate failed to meet primary and key secondary goals in a late-stage trial.
View full resource at online.wsj.com
Tags: Cystic Fibrosis, Drug, Pharma
Most Recently Shared on January 3, 2011 at 3:25 pm By:
Inspire's Cystic Fibrosis Treatment Misses Goals http://on.wsj.com/g1mliR
Advertisement
